Painchek Ltd (PCK) - Net Assets
Based on the latest financial reports, Painchek Ltd (PCK) has net assets worth AU$-1.11 Million AUD (≈ $-787.47K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$2.15 Million ≈ $1.52 Million USD) and total liabilities (AU$3.26 Million ≈ $2.31 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Painchek Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-1.11 Million |
| % of Total Assets | -51.77% |
| Annual Growth Rate | N/A |
| 5-Year Change | -113.5% |
| 10-Year Change | N/A |
| Growth Volatility | 375.87 |
Painchek Ltd - Net Assets Trend (2011–2025)
This chart illustrates how Painchek Ltd's net assets have evolved over time, based on quarterly financial data. Also explore PCK total assets for the complete picture of this company's asset base.
Annual Net Assets for Painchek Ltd (2011–2025)
The table below shows the annual net assets of Painchek Ltd from 2011 to 2025. For live valuation and market cap data, see Painchek Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$-1.11 Million ≈ $-787.47K |
-186.25% |
| 2024-06-30 | AU$1.29 Million ≈ $913.02K |
+93.13% |
| 2023-06-30 | AU$668.13K ≈ $472.75K |
-86.15% |
| 2022-06-30 | AU$4.82 Million ≈ $3.41 Million |
-41.49% |
| 2021-06-30 | AU$8.24 Million ≈ $5.83 Million |
+99.70% |
| 2020-06-30 | AU$4.13 Million ≈ $2.92 Million |
+0.18% |
| 2019-06-30 | AU$4.12 Million ≈ $2.92 Million |
+27.79% |
| 2018-06-30 | AU$3.22 Million ≈ $2.28 Million |
+29.89% |
| 2017-06-30 | AU$2.48 Million ≈ $1.76 Million |
+371.36% |
| 2016-06-30 | AU$-914.86K ≈ $-647.32K |
-161.95% |
| 2015-06-30 | AU$1.48 Million ≈ $1.04 Million |
+83.66% |
| 2014-06-30 | AU$804.15K ≈ $568.99K |
-37.93% |
| 2013-06-30 | AU$1.30 Million ≈ $916.75K |
-45.75% |
| 2012-06-30 | AU$2.39 Million ≈ $1.69 Million |
+1354.18% |
| 2011-06-30 | AU$164.24K ≈ $116.21K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Painchek Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6451940600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$47.60 Million | % |
| Other Comprehensive Income | AU$15.84 Million | % |
| Total Equity | AU$-1.11 Million | 100.00% |
Painchek Ltd Competitors by Market Cap
The table below lists competitors of Painchek Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Haily Group Bhd
KLSE:0237
|
$20.71 Million |
|
Sala @ Sathorn Property Fund
BK:SSPF
|
$20.72 Million |
|
ASIASOFT CORP.-NVDR-05
F:5ASA
|
$20.72 Million |
|
Wealth Minerals Ltd.
V:WML
|
$20.72 Million |
|
Upland Software Inc
NASDAQ:UPLD
|
$20.70 Million |
|
Roctool
PA:ALROC
|
$20.70 Million |
|
Yonga Mobilya Sanayi ve Ticaret AS
IS:YONGA
|
$20.70 Million |
|
Ziga Innovation Public Company Limited
BK:ZIGA
|
$20.68 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Painchek Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,290,370 to -1,112,927, a change of -2,403,297 (-186.2%).
- Net loss of 7,672,226 reduced equity.
- Share repurchases of 5,123,330 reduced equity.
- Other comprehensive income increased equity by 1,054,115.
- Other factors increased equity by 9,338,144.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-7.67 Million | -689.37% |
| Share Repurchases | AU$5.12 Million | -460.35% |
| Other Comprehensive Income | AU$1.05 Million | +94.72% |
| Other Changes | AU$9.34 Million | +839.06% |
| Total Change | AU$- | -186.25% |
Book Value vs Market Value Analysis
This analysis compares Painchek Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-06-30 | AU$0.16 | AU$0.14 | x |
| 2012-06-30 | AU$2.41 | AU$0.14 | x |
| 2013-06-30 | AU$0.72 | AU$0.14 | x |
| 2014-06-30 | AU$0.43 | AU$0.14 | x |
| 2015-06-30 | AU$0.36 | AU$0.14 | x |
| 2016-06-30 | AU$-0.07 | AU$0.14 | x |
| 2017-06-30 | AU$0.05 | AU$0.14 | x |
| 2018-06-30 | AU$0.00 | AU$0.14 | x |
| 2019-06-30 | AU$0.00 | AU$0.14 | x |
| 2020-06-30 | AU$0.00 | AU$0.14 | x |
| 2021-06-30 | AU$0.01 | AU$0.14 | x |
| 2022-06-30 | AU$0.04 | AU$0.14 | x |
| 2023-06-30 | AU$0.00 | AU$0.14 | x |
| 2024-06-30 | AU$0.01 | AU$0.14 | x |
| 2025-06-30 | AU$-0.01 | AU$0.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Painchek Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -228.18%
- • Asset Turnover: 1.56x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-212.01%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | -24.89% | 0.00% | 0.00x | 1.35x | AU$-57.30K |
| 2012 | -16.98% | 0.00% | 0.00x | 1.02x | AU$-644.47K |
| 2013 | -84.85% | 0.00% | 0.00x | 1.07x | AU$-1.23 Million |
| 2014 | -98.52% | 0.00% | 0.00x | 1.19x | AU$-872.68K |
| 2015 | -115.36% | -309769.64% | 0.00x | 1.58x | AU$-1.85 Million |
| 2016 | 0.00% | -129687.80% | 0.03x | 0.00x | AU$-4.96 Million |
| 2017 | -341.33% | -27232.94% | 0.01x | 1.08x | AU$-8.72 Million |
| 2018 | -149.18% | -9498.16% | 0.01x | 1.14x | AU$-5.13 Million |
| 2019 | -79.17% | -1514.14% | 0.05x | 1.15x | AU$-3.67 Million |
| 2020 | -300.18% | -4993.13% | 0.04x | 1.51x | AU$-12.81 Million |
| 2021 | -73.55% | -2822.95% | 0.02x | 1.43x | AU$-6.89 Million |
| 2022 | -118.60% | -584.58% | 0.15x | 1.38x | AU$-6.20 Million |
| 2023 | -1133.72% | -388.54% | 0.70x | 4.18x | AU$-7.64 Million |
| 2024 | -643.84% | -310.93% | 0.64x | 3.24x | AU$-8.44 Million |
| 2025 | 0.00% | -228.18% | 1.56x | 0.00x | AU$-7.56 Million |
Industry Comparison
This section compares Painchek Ltd's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $3,017,798
- Average return on equity (ROE) among peers: -62.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Painchek Ltd (PCK) | AU$-1.11 Million | -24.89% | N/A | $20.70 Million |
| Adheris Health Limited (AHE) | $-106.88K | 0.00% | 0.00x | $137.44 |
| Alcidion Group Ltd (ALC) | $4.18 Million | -28.59% | 0.01x | $104.52 Million |
| ARTRYA Ltd (AYA) | $16.80 Million | -83.31% | 0.13x | $537.30 Million |
| Beamtree Holdings Ltd (BMT) | $20.17 Million | -4.62% | 0.06x | $18.51 Million |
| Cogstate Ltd (CGS) | $1.34 Million | -104.39% | 0.49x | $318.03 Million |
| Careteq Ltd (CTQ) | $-3.74 Million | 0.00% | 0.00x | $6.42 Million |
| Doctor Care Anywhere Group Plc (DOC) | $12.29 Million | -179.31% | 0.79x | $37.62 Million |
| Echoiq Ltd (EIQ) | $3.12 Million | -85.90% | 0.33x | $654.64 Million |
| Emyria Ltd (EMD) | $3.78 Million | -138.47% | 0.34x | $23.97 Million |
| Enlitic Inc (ENL) | $-27.66 Million | 0.00% | 0.00x | $5.31 Million |
About Painchek Ltd
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate th… Read more